<DOC>
	<DOCNO>NCT00563212</DOCNO>
	<brief_summary>Idiopathic pulmonary fibrosis ( IPF ) progressive disease effective treatment . Interferon-gamma medication use lung diseases decrease scar fibrosis . Studies interferon-gamma injected skin show improvement survival patient IPF . We hypothesize give interferon-gamma nebulized mist directly lungs affect immune system way decrease fibrosis .</brief_summary>
	<brief_title>A Pilot Study Aerosol Interferon-gamma Treatment Idiopathic Pulmonary Fibrosis</brief_title>
	<detailed_description>Patients mild-to-moderate idiopathic pulmonary fibrosis ( IPF ) enrol phase I study aerosol interferon-gamma ( IFN-γ ) . Prior initiation treatment , patient undergo CT chest , pulmonary function testing , bronchoscopy bronchoalveolar lavage . They also undergo lung deposition study determine lung dose IFN-γ deliver treatment . Patients receive aerosol IFN-γ 100mcg deliver three time weekly via nebulizer one year . Study patient follow monthly monitor potential side effect , vital sign , progression IPF symptom . Labs drawn regular interval monitor side effect measure cytokine level . Bronchoscopy perform 6 and/or 12 month visit compare cytokine level pre- , , post-treatment .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>Patients diagnose IPF base accept criterion ( see ) within 12 month prior screen . Age 4075 . Absence significant pulmonary hypertension measure right heart catheterization ( mPAP ≥ 30 mmHG ) echocardiography ( RVSP ≥ 50 mmHg ) . FVC ≥ 55 % predict baseline value screening ; DLCO ≥ 30 % predict . PaO2 ≥ 65 mm Hg rest room air Patient able understand willing sign write informed consent willing comply requirement study protocol include lung deposition study . Patient fit criterion research bronchoscopy willing undergo procedure . Six minute walk distance &lt; 200 meter . Patient unwilling unable undergo research bronchoscopy . Patient known life threaten asthma severe COPD . Patient require oxygen therapy maintenance adequate arterial oxygenation rest . Patient hypersensitivity study medication component medication . Patient know severe cardiac disease , severe peripheral vascular disease seizure disorder may exacerbate study drug administration ( contraindication drug administration per package insert ) . Pregnant lactating ; Females childbearing potential require negative pregnancy test require use accepted form birth control ( abstinence study duration prefer method ) . Evidence active infection within one week prior treatment . Any condition , IPF , likely result death patient within one year study enrollment . Abnormal serum laboratory value include : Liver function specify limit : total bilirubin &gt; 1.5 X upper limit normal , alanine amino transferase &gt; 3X upper limit normal , alkaline phosphatase &gt; 3X upper limit normal , albumin &lt; 3.0 screening . CBC outside specify limit : WBC &lt; 2,500/mm3 , hematocrit &lt; 30 &gt; 59 , platelet &lt; 100,000/mm3 . Creatinine &gt; 1.5X upper limit normal screen . Drugs therapy pulmonary fibrosis , include corticosteroid , azathioprine and/or cyclophosphamide , nacetylcysteine within previous six week . Prior therapy class interferon medication . Investigational therapy indication within last 28 day . In pulmonary rehabilitation program planning attend pulmonary rehabilitation program .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Lung Diseases , Interstitial</keyword>
	<keyword>Fibrosis</keyword>
	<keyword>Interferons</keyword>
	<keyword>Pulmonary Fibrosis</keyword>
	<keyword>Pathologic Processes</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Fibrosing alveolitis</keyword>
	<keyword>Interferon-gamma , Recombinant</keyword>
	<keyword>Aerosols</keyword>
</DOC>